Next-Generation Sequencing

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights important takeaways for interventional pulmonologists and other providers who may see patients with EGFR-mutated lung cancer.

Rates of next-generation sequencing have increased for individuals with metastatic prostate cancer or advanced urothelial carcinoma over the past several years, but more than half of these individuals still do not undergo testing.

Next-generation sequencing has emerged as a revolutionary tool with extensive applications in medicine ranging from cancer screening to diagnosing infections across specialties, including orthopedic surgery.

MADRID — Hossein Borghaei, DO, MS, discussed results from the PAPILLON trial, which combined amivantamab and chemotherapy as first-line treatment for EGFR exon 20 insertion-mutated non-small cell lung cancer, in a video interview.

PHILADELPHIA — Immunologic risk assessment with a  blood-based next-generation sequencing tool may be able to predict the risk of early acute kidney rejection before transplantation, according to research presented at ASN Kidney Week.

CHICAGO — ChatGPT can be used to develop next-generation sequencing reports that outline treatment strategies for patients who have non-small cell lung cancer with driver oncogenes, according to results presented at ASCO Annual Meeting.

Next-generation sequencing and precision medicine techniques have enabled the identification of millions of somatic cancer variants.

In their most recent column, Sanjeev Bhatia, MD, and David B. Mandell, JD, MBA, explain tax loss harvesting and how it can be an effective strategy for reducing tax obligations. It was the top story in hematology/oncology last week.